In 2023, the mortality rate of liver malignant neoplasms in Brazil stood at 5.4 deaths per hundred thousand persons. Forecasts indicate a steady increase, reaching 5.8 by 2028. Year-on-year, this represents an increase of approximately 1.8% from 2024 to 2025, remaining consistent with minor fluctuations until the forecast end. The compound annual growth rate (CAGR) over the five-year forecast period is expected to be 1.8% annually.
Looking forward, significant factors to monitor include advancements in liver cancer treatments and public health interventions. Additionally, changes in risk factors such as alcohol consumption and hepatitis infection rates could influence future mortality rates.
